Healthcare technology should be replaced every ten years, with proper maintenance throughout its lifecycle to ensure safety, accuracy, and efficiency. Fenin’s new guide, based on Cocir’s...
Biotechnology has surged in Galicia, especially Pontevedra, now second only to Catalonia. The sector generates €1.5 billion annually, 2% of Galician GDP, with significant growth post-COVID....
Spain’s public healthcare spending rose to €97.66 billion in 2023, up 6.2%. Pharmaceutical spending hit a historic low share of 14.3% despite nominal growth. Public health...
Bioga and CESGA strengthen their 15-year collaboration to boost Galicia’s biotech sector using high-performance computing. Their joint efforts aim to cut drug development costs and time,...
A Carlos III Health Institute team showed CRISPR-based gene therapy effectively targets Ewing sarcoma in preclinical models. Using a tumor-specific promoter, the treatment avoids harming healthy...
CNIC researchers have developed a promising gene therapy for ARVC5, a lethal genetic heart disease. By delivering a healthy TMEM43 gene via AAV vectors, they improved...
Biotech stocks are currently out of favor, but analysts believe sentiment may have bottomed out, creating a buying opportunity—especially for undervalued small and mid-cap firms. Concerns...
Northwestern University researchers have created the world’s smallest, dissolvable pacemaker for critically ill newborns. Injected via syringe and activated by a chest patch using infrared light,...
The CNAG closed 2024 as a leader in precision medicine, doubling sequencing capacity and advancing diagnostics for complex diseases. It contributed to major projects, including rare...
AstraZeneca and 13 scientific societies signed a document promoting a multidisciplinary approach to cardio-renal-metabolic diseases. The agreement emphasizes early diagnosis, care coordination, research, awareness, screening, equitable...